Background: A significant proportion of hereditary non-polyposis colorectal cancer, which has a high risk of synchronous and/or metachronous multiple primary tumors of the colon (Lynch I) or other organs (Lynch II) at a young patient age, is caused by the inheritance of germline mutations in at least 4 genes such as hMSH2, hMLH1, hPMS1, and hPMS2. Accordingly, gene analysis by a noninvasive method would be clinically useful.
INTRODUCTION
The true incidence of colorectal cancer due to hereditary non-polyposis colorectal cancer is still controversial, although this is one of the most commonly known hereditary diseases in humans. Because of the lack of a specific phenotype before the development of cancer, the diagnosis of hereditary non-polyposis colorectal cancer is mainly based on the patient's medical history, and there is some difficulty in eliminating familial clustering of colorectal cancer.
This disease is characterized by the development of synchronous and/or metachronous multiple primary tumors of the colon (Lynch I) or other organs (Lynch II), 1 often before 50 years of age. Hereditary nonpolyposis colorectal cancer is clinically defined by the early onset of colon cancer and other specific cancers in first-degree relatives over at least 2 generations. 2 The predisposition is inherited in an autosomal dominant fashion, and it was one of the first familial cancer syndromes recognized. However, its molecular pathogenesis has only recently been identified. A significant portion of hereditary non-polyposis colorectal cancer is caused by the inheritance of germline mutations in at least 4 genes, hMSH2, 3,4 hMLH1, ~-7 hPMS1, and hPMS2, 8 which encode components of the DNA mismatch repair system. These DNA mismatch repair genes are vital to preservation of the fidelity of DNA replication, and if mutation occurs in these DNA mismatch repair genes, the occurrence of mismatch increases by 100-to 1000-fold, when compared to patients with normal DNA mismatch repair genes. 9'1~ A combination of linkage and mutational analysis has indicated that h M S H 2 and h M L H 1 are the most c o m m o n , and second most prevalent, hereditary nonpolyposis colorectal cancer genes, accounting for 40% to 60% ,and about 30%, of hereditary non-polyposis colorectal cancer, respectively. It has been suggested that the wild-type allele of inherited hereditary nonpolyposis colorectal cancer genes is inactivated during tumor formation, thereby increasing the mutation of oncogenes or tumor suppressor genes that are involved in the adenoma-carcinoma sequence, and accelerating tumor progression. 11
Since family m e m b e r s of persons with hereditary non-polyposis colorectal cancer have a very high risk of developing colon cancer or other neoplasms at an early age, the discovery of germline mutation-positive individuals is useful to determine whether or not they should have periodic screening throughout life. T o analyze germline mutation, genomic D N A is usually extracted from white blood cells. However, this method has the following problems: 1) the family members must undergo venipuncture to collect blood samples for analysis of their genes, and 2) the examiners are at risk of infection by blood-borne viruses such as the h u m a n immunodeficiency virus and hepatitis C virus when needle-stick accidents occur. Accordingly, this method is thought to be unsuitable for mass screening of family m e m b e r s of persons with hereditary non-polyposis colorectal cancer. T o solve these problems, we performed mutation analysis to detect a known missense mutation in a large hereditary non-polyposis colorectal cancer pedigree by using both blood samples and mouthwash samples ~2,13 and 3 convenient polymerase chain reaction (PCR)-related techniques.
SUBJECTS AND METHODS
After obtaining informed consent from each subject (in the case of individuals younger than 15 years old, we obtained consent from parents or legal guardians), we examined 20 individuals (including the proband) of the 148 members spanning 5 generations of the largest hereditary non-polyposis colorectal cancer pedigree in Japan. T h e proband of this hereditary non-polyposis colorectal cancer pedigree was previously found to have a missense mutation of the h M L H 1 gene at the site of the first base of codon 582 in exon 16 ( C T C to G T C ; leucine to valine). 14 T h e present analysis showed that 4 other persons with carcinoma had the same missense mutations (Fig. 1 ).
Informed Consent
T h e information given to obtain informed consent was as follows. Clustering of colorectal cancer and other malignancies has been detected by taking a history of your family, which fulfills the Amsterdam criteria for hereditary non-polyposis colorectal cancer. T h e proband has a missense mutation of the h M L H 1 gene at the site of the first base of codon 582 in exon 16. We have not yet examined whether or not this genotype has a relationship to the cancer phenotype. But if this genotype causes carcinogenesis, gene testing of family m e m b e r s will be useful for detecting early asymptomatic cancer, because family members of persons with hereditary non-polyposis colorectal cancer have a higher risk of developing colorectal cancer. T o analyze germline m utations, genomic D N A is usually extracted from white blood cells, but we will also perform gene testing using mouthwash precipitates that contain exfoliated mucosal cells. We would like to collect blood samples and mouthwash samples from you. T h e information acquired will be discussed at our institute and provided to each individual subject. ) and the proband of this pedigree. Electrophoresis was performed on 8% polyacrylamide gel that was stained by ethidium bromide. PCR fragments were 82 bp in length and the missense mutation was at the first base of codon 582 in exon 16 of hMLH1. M, molecular marker; C, internal control; P, proband of the hereditary non-polyposis colorectal cancer pedigree; roman numerals indicate generation number. and the tubes were incubated in the water bath at 56~ for 3 hours. T h e phenol-chloroform method was applied to extract genomic D N A from the products, as described elsewhere. 15 Extracted D N A was diluted in 100 /2L of sterile water. Since the total a m o u n t of extracted genomic D N A was very small, the concentration could not be determined, and it was directly applied to the PCR. MgCI2), and 0.1% TritonX-100. After the mixture was denatured at 95~ for 8 minutes, it was subjected to 35 cycles of P C R amplification (denaturation at 94~ for 1.5 minutes, annealing at 60~ for 1.5 minutes, and extension at 73~ for 1 minute) in a thermal cycler (Gene A m p P C R system, Model 480; Perkin Elmer Cetus, Foster City, CA, USA). T h e length of the products was confirmed by electrophoresis on 6% N u s i e v e -G T G agarose gel (Takara, Tokyo, Japan) with a ~X174 HaeIII-digested molecular marker (Boehringer M a n n h e i m G m b H , Mannheim, Germany), and staining by ethidium bromide. T h e products were then purified into 20 to 30/2L of solution by spin dialysis through a Millipore Ultra-free-MC filter with a 30,000 dalton cut-off point (Millipore Products Division, Bedford, USA) and were used for enzyme digestion or direct sequencing.
Genomic DNA Extraction

Polymerase Chain Reaction
Restriction Fragment Length Polymorphism (Restriction Enzyme Digestion)
T h e purified P C R products were digested with 10 units of restriction enzyme MspI at 37~ for 2 hours in a buffer 16 (Fig. 2) . P C R products (136 bp in length) were amplified using PM171 and PM173. If the mutation was absent, the P C R products were digested into 2 fragments which were 116 bp and 20 bp in length. In the presence of the missense mutation at the first base of codon 582 ( C T C to G T C ) , the P C R products were digested into 3 fragments that were 34 bp, 82 bp, and 20 bp in length. T h e n 5/2L of each digested product was loaded onto agarose gel with the ~X 1 7 4 HaeIII-digested molecular marker to analyze the length.
Allele-Specific Polymerase Chain Reaction (AS-PCR)
To confirm the results of restriction fragment length polymorphism (RFLP) analysis, A S -P C R 16 ( Fig. 3) was performed with 20 /2L of the D N A sample solution described above. Half (10/~L) of the solution was used for 1 PCR with PM172 (5'-TCAGCCq'I'Cq~I'CTTCAGAAACT -3', 22met) and PM174 (5'-CCTAGGAGCC AGCACCGC-3', 18mer) primers. T h e other 10/2L was used for another P C R with P M 1 7 2 a n d p r i m e r P M 1 7 5 (5'-CCTAGGAGCCAGC~CCGG-3', 18met). The sequence of PM174 was identical with part of the sense sequence of genomic DNA, and the 3' end was composed of cytosine corresponding with the first base ofcodon 582 in exon 16. The sequence o f P M 175 was the same as that o f P M 174, except that the 3' end of the primer had cytosine transformed into guanine. P C R amplifications were confirmed by an agarose gel electrophoresis described before.
PCR-Direct Sequencing
T o further confirm the results of R F L P analysis and AS-PCR, 10 ~tL of the D N A solution was used for PCRdirect sequencing under the conditions described above. PCR was performed with the D N A solution and PM 171 and PM172 to produce 152 bp fragments containing the mutation site. P C R products were confirmed by agarose gel electrophoresis and purified by spin dialysis. T h e purified products were reacted with deoxyribonucleoside triphosphates (dNTPs), fluorescent dye- None --aEach sample is matched to that in the pedigree shown in Fig. 5 ; RFLP, restriction fragment length polymorphism; AS, allele specific; +, mutation positive;-, mutation negative.
City, CA, USA), Taq DNA polymerase, and 3 pmol of PM173 as a sequencing primer in the PCR thermal cycler under the conditions recommended by the manufacturer. The reaction products were purified by phenol-chloroform extraction and were loaded onto polyacrylamide gel in the automated DNA sequencer (Applied Biosystems, ABI373A).
RESULTS
We examined mouthwash samples from 20 of the 148 family members. Figures 2 and 3 show typical results obtained by PCR-RFLP and AS-PCR, respectively, and Fig. 4 shows the results obtained with automated DNA sequencing. The data obtained by the 3 detection methods are summarized in Table 1 . Figure 5 shows the results in pedigree form. Six subjects (including the proband, case no. III-7) were recognized as carriers of the gene mutation. Examination of the gastrointestinal tract and gynecologic organs showed that 5 of the 6 persons are still free of tumors. Our initial study showed a dilemma. A woman (case no. IV-6) who was in the fourth generation had the mutation, but we could not find a germline mutation of the hMLH1 gene in her mother who did not have any malignancies even in the fifth decade of her life. We decided to trace the mutation in her father who had undergone surgery for gastric cancer, and found in him the very same hMLH1 gene mutation as in the other carriers. Further analysis of this pedigree showed that there was intermarriage between close relatives and that the gene alteration was inherited from her father.
To confirm the accuracy of this method, we also analyzed DNA extracted from blood cell samples in 14 subjects. The results obtained from mouthwash samples agreed with those from the blood cell samples (Fig. 6 ).
DISCUSSION
Mutation of the hMLH1 gene has already been reported 3-6,1s in a limited number of cases. Since we have not yet functionally examined whether or not this missense mutation of hMLH1 might cause the cancer phenotype in this pedigree, we could not distinguish whether the missense mutation was a true functional mutation or polymorphism. To determine whether or not this missense mutation, a C to G substitution resulting in an amino acid changing from leucine to valine, was a polymorphism, we examined C to G substitutions at the site of first base ofcodon 582 in exon 16 of hMLH1 in 60 unrelated individuals using the PCR-RFLP method. 5 C to G substitutions were not detected in any of these 60 unrelated individuals, so the substitution did not appear to be polymorphism. Moreover, the existence of this mutation in all 6 persons with cancer who were examined (including the husband of case no. III-2) made us suspect that this genotype might have a certain relationship to the cancer phenotype. Therefore, ~t is necessary to continue to follow up the m e m b e r s of this family carefully.
T h e results obtained by analysis of mouthwash precipitates were in~greement with those obtained from blood samples in the 14 subjects studied both ways, which suggested that our mouthwash method could be a substitute for detection using blood samples. Since family m e m b e r s of persons with hereditary non-polyposis colorectal cancer have a very high risk of developing colon cancer or other neoplasms in their early years, a noninvasive examination method would be very useful to determine whether or not periodical checks should be done throughout life.
In general, analysis of germline mutations is performed using blood samples, but this method is unsuitable for mass screening of family m e m b e r s of persons with hereditary non-polyposis colorectal cancer because all the persons involved would have to undergo venipuncture to take blood samples for gene analysis and the examiners are at risk of infection by blood-borne viruses when needle-stick accidents occur. In the case of using mouthwash sample precipitates, the samples can be collected at h o m e and sent by mail (at a low temperature) to an institute where gene analysis is performed. Moreover, the examiners have little risk of infection by blood-borne viruses, because there is no need to use needles. Accordingly, gene analysis with mouthwash samples is considered to be easier and safer than that with blood samples, and may be more helpful for the screening of family m e m b e r s of persons with hereditary non-polyposis colorectal cancer.
Detection of a mutation in the proband of a hereditary non-polyposis colorectal cancer pedigree is still laborious and time consuming, because the genes that might be responsible for neoplastic transformation in hereditary non-polyposis colorectal cancer are unclear, in contrast with familial adenomatous polyposis, which is caused by dysfunction of the APC gene. 19 In addition, the mutation site seems to be different in every hereditary non-polyposis colorectal cancer pedigree. 14 In familial adenomatous polyposis, penetrance is very high, and a person with the germline mutation will develop the disease with 100% certainty. However, the penetrance of hereditary non-polyposis colorectal cancer is not yet established. In our case, a germline mutation of the hMSH2 gene was not detected. Accordingly, further analysis would be necessary to determine whether or not this point mutation caused carcinogenesis in the proband.
Genetic testing can be beneficial to individual subjects, but it still has advantages and disadvantages. Existing tests fail to detect mutations in 20% to 40% of individuals with typical hereditary non-polyposis colorectal cancer. This suggests the possibility that unknown hereditary nonpolyposis colorectal cancer-related genes might cause carcinogenesis. Accordingly, it is necessary to examine and follow-up the individuals with hereditary non-polyposis colorectal cancer who have not yet been affected by malignancy. In conclusion, we detected a known missense mutation from the proband and 4 other subjects with cancer in a large hereditary non-polyposis colorectal cancer pedigree by using mouthwash precipitates and 3 convenient PCR-related techniques.
DNA extraction from mouthwash precipitates is delicate and requires careful handling of the reagents and equipment. However, once a mutation is found in a specific gene, it is relatively easy to perform gene analysis of the family members. Our method may be useful for screening possible hereditary non-polyposis colorectal cancer carriers, because it is a convenient and noninvasive diagnostic procedure.
